Thursday, May 27, 2021 1:18:57 PM
No, not a fan of fluff PRs at all. Those are ridiculous and add no long-term benefit to the company.
The management of the outstanding shares is abysmal at best. Management will have to do something about it before going to an exchange, which means if they are avoiding a small consistent share buyback (which would stabilize the price, decrease volatility, bring in new investors and drive the share price up by creating a rising floor), they are sold on a reverse split. A very small consistent buyback portrays confidence in the company, especially with the colossal outstanding float.
What management is lacking is confidence from investors due to the consistent inability to execute the majority of their communicated plans. I think this is the partial reason why Nasrat is quiet on future plans since very little has come to fruition over the past 8 years. Why set the bar if it’s always out of reach and get blamed for it. Less accountability if you don’t set goals. Most CEOs will under promise and over deliver - it’s been the exact opposite since Nasrat started.
The management of the outstanding shares is abysmal at best. Management will have to do something about it before going to an exchange, which means if they are avoiding a small consistent share buyback (which would stabilize the price, decrease volatility, bring in new investors and drive the share price up by creating a rising floor), they are sold on a reverse split. A very small consistent buyback portrays confidence in the company, especially with the colossal outstanding float.
What management is lacking is confidence from investors due to the consistent inability to execute the majority of their communicated plans. I think this is the partial reason why Nasrat is quiet on future plans since very little has come to fruition over the past 8 years. Why set the bar if it’s always out of reach and get blamed for it. Less accountability if you don’t set goals. Most CEOs will under promise and over deliver - it’s been the exact opposite since Nasrat started.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
